908 Devices (MASS) Consolidated Net Income (2020 - 2026)
908 Devices (MASS) reported Consolidated Net Income of -$11.9 million for Q1 2026, down 122.36% year-over-year from $53.4 million in Q1 2025, and down 5756.86% quarter-over-quarter from -$204000.0 in Q4 2025.
908 Devices (MASS) Consolidated Net Income (2020 - 2026) Analysis & Trends
908 Devices (MASS) has 7 years of Consolidated Net Income data on file, last reported at -$11.9 million in Q1 2026.
- Consolidated Net Income for Q1 2026 came in at -$11.9 million, down 122.36% year-over-year; the trailing twelve-month figure through Mar 2026 was -$12.6 million (down 132.04% YoY), and the FY2025 annual result was $52.8 million, up 376.75% from the prior year.
- Consolidated Net Income fell to -$11.9 million in Q1 2026 per MASS's latest filing, from -$204000.0 in the prior quarter.
- Over five years, Consolidated Net Income peaked at $53.4 million in Q1 2025 and troughed at -$12.5 million in Q1 2023.
- A 5-year average of -$2.8 million and a median of -$6.3 million in 2022 frame the typical range for Consolidated Net Income.
- The sharpest annual moves came in 2022 and 2025: Consolidated Net Income slumped 174.41% in 2022, then soared 1164.12% in 2025.
- A 5-year view of Consolidated Net Income shows it stood at -$9.8 million in 2022, then increased by 24.12% to -$7.4 million in 2023, then surged by 53.94% to -$3.4 million in 2024, then soared by 94.04% to -$204000.0 in 2025, then tumbled by 5756.86% to -$11.9 million in 2026.
- Business Quant data shows MASS's Consolidated Net Income at -$11.9 million in Q1 2026, -$204000.0 in Q4 2025, and -$72000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 411.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 199.50 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | 908 Devices | 304.12 Mn | 192.38 Mn | 6.88 Mn | -11.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.95 Mn |
| Dec 31, 2025 | -204,000.00 |
| Sep 30, 2025 | -72,000.00 |
| Jun 30, 2025 | -398,000.00 |
| Mar 31, 2025 | 53.44 Mn |
| Dec 31, 2024 | -3.42 Mn |
| Sep 30, 2024 | -5.65 Mn |
| Jun 30, 2024 | -4.98 Mn |
| Mar 31, 2024 | -5.02 Mn |
| Dec 31, 2023 | -7.43 Mn |
| Sep 30, 2023 | -7.09 Mn |
| Jun 30, 2023 | -9.35 Mn |
| Mar 31, 2023 | -12.53 Mn |
| Dec 31, 2022 | -9.79 Mn |
| Sep 30, 2022 | -6.26 Mn |
| Jun 30, 2022 | -8.10 Mn |
| Mar 31, 2022 | -9.37 Mn |
| Dec 31, 2021 | -3.57 Mn |
| Sep 30, 2021 | -5.31 Mn |
| Jun 30, 2021 | -7.49 Mn |